FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3142911000001109: Hydroxyapatite 830mg tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22218701000001113 Hydroxyapatite 830mg tablets 50 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22218801000001116 Hydroxyapatite 830mg tablets 50 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxyapatite 830mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has specific active ingredient Hydroxyapatite true Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Is pack of Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) false Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has active ingredient Hydroxyapatite false Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has active ingredient Nutritional supplement false Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has active ingredient Genitourinary agent false Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has VMP Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has specific active ingredient Hydroxyapatite false Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ossopan 800 tablets (Sanofi-Synthelabo Ltd) 50 tablet 5 x 10 tablets Is a True Hydroxyapatite 830mg tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start